Cargando…
Safety of serotonin (5-HT3) receptor antagonists in patients undergoing surgery and chemotherapy: protocol for a systematic review and network meta-analysis
BACKGROUND: Serotonin (5-HT3) receptor antagonists are a class of antiemetic medications often used to prevent nausea and vomiting among patients undergoing chemotherapy, radiotherapy or surgery. However, recent studies suggest that these agents might be associated with increased cardiac harm. To ex...
Autores principales: | Tricco, Andrea C, Soobiah, Charlene, Antony, Jesmin, Hemmelgarn, Brenda, Moher, David, Hutton, Brian, Straus, Sharon E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702491/ https://www.ncbi.nlm.nih.gov/pubmed/23810058 http://dx.doi.org/10.1186/2046-4053-2-46 |
Ejemplares similares
-
Interventions to decrease the risk of adverse cardiac events for post-surgery or chemotherapy patients taking serotonin (5-HT3) receptor antagonists: protocol for a systematic review and network meta-analysis
por: Tricco, Andrea C, et al.
Publicado: (2013) -
Interventions to decrease the risk of adverse cardiac events for patients receiving chemotherapy and serotonin (5-HT3) receptor antagonists: a systematic review
por: Tricco, Andrea C, et al.
Publicado: (2015) -
Safety, effectiveness, and cost of dipeptidyl peptidase-4 inhibitors versus intermediate acting insulin for type 2 diabetes: protocol for a systematic review and network meta-analysis
por: Tricco, Andrea C, et al.
Publicado: (2013) -
Comparative safety of serotonin (5-HT(3)) receptor antagonists in patients undergoing surgery: a systematic review and network meta-analysis
por: Tricco, Andrea C, et al.
Publicado: (2015) -
Comparative efficacy of serotonin (5-HT(3)) receptor antagonists in patients undergoing surgery: a systematic review and network meta-analysis
por: Tricco, Andrea C., et al.
Publicado: (2015)